Felzmann, T; Buchroithner, J; Marosi, C; Nowosielsky, M; Oberndorfer, S; Ruckser, R; Rossler, K; Azizi, A; von Campe, G; Bordihn, K; The Austrian GBM-Vax consortium.
First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.
CANCER RES. Abstract Nr 4658 . 2013; 73 (8 Suppl): -Proceedings of the 104th Annual Meeting of the American Association for Cancer Research (AACR); APR 06-10, 2013; Washington, DC.
Doi: 10.1158/1538-7445.AM2013-4658
[Poster]
Web of Science
FullText
FullText_MUG